JP Morgan Chase’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $195M | Buy |
1,649,400
+896,100
| +119% | +$103M | 0.01% | 707 |
|
|
2025
Q4 | $79.3M | Buy |
753,300
+21,400
| +3% | +$2.01M | 0.01% | 1062 |
|
|
2025
Q3 | $61.4M | Buy |
731,900
+120,000
| +20% | +$9.88M | ﹤0.01% | 1283 |
|
|
2025
Q2 | $48.4M | Buy |
611,900
+325,000
| +113% | +$25.8M | ﹤0.01% | 1344 |
|
|
2025
Q1 | $25.8M | Sell |
286,900
-200,300
| -41% | -$18.7M | ﹤0.01% | 1716 |
|
|
2024
Q4 | $48.5M | Buy |
487,200
+228,800
| +89% | +$23.6M | ﹤0.01% | 1346 |
|
|
2024
Q3 | $29.3M | Buy |
258,400
+17,100
| +7% | +$2.03M | ﹤0.01% | 1699 |
|
|
2024
Q2 | $29.9M | Sell |
241,300
-1,048,000
| -81% | -$135M | ﹤0.01% | 1560 |
|
|
2024
Q1 | $170M | Buy |
1,289,300
+1,136,700
| +745% | +$140M | 0.01% | 706 |
|
|
2023
Q4 | $16.6M | Sell |
152,600
-188,800
| -55% | -$19.6M | ﹤0.01% | 1996 |
|
|
2023
Q3 | $35.1M | Buy |
341,400
+44,500
| +15% | +$4.8M | ﹤0.01% | 1292 |
|
|
2023
Q2 | $34.3M | Sell |
296,900
-98,200
| -25% | -$11.1M | ﹤0.01% | 1307 |
|
|
2023
Q1 | $42M | Sell |
395,100
-353,600
| -47% | -$38.2M | 0.01% | 1187 |
|
|
2022
Q4 | $83.1M | Sell |
748,700
-80,200
| -10% | -$8.2M | 0.01% | 863 |
|
|
2022
Q3 | $71.4M | Buy |
828,900
+148,000
| +22% | +$13.2M | 0.01% | 874 |
|
|
2022
Q2 | $62.1M | Buy |
680,900
+396,890
| +140% | +$35.2M | 0.01% | 937 |
|
|
2022
Q1 | $23.3M | Sell |
284,010
-1,364,590
| -83% | -$108M | ﹤0.01% | 1651 |
|
|
2021
Q4 | $126M | Sell |
1,648,600
-1,442,700
| -47% | -$115M | 0.01% | 778 |
|
|
2021
Q3 | $232M | Buy |
3,091,300
+3,043,450
| +6,360% | +$231M | 0.03% | 531 |
|
|
2021
Q2 | $3.72M | Buy |
47,850
+6,559
| +16% | +$488K | ﹤0.01% | 3299 |
|
|
2021
Q1 | $3.04M | Sell |
41,291
-45,483
| -52% | -$3.36M | ﹤0.01% | 3388 |
|
|
2020
Q4 | $6.77M | Sell |
86,774
-24,104
| -22% | -$1.84M | ﹤0.01% | 2541 |
|
|
2020
Q3 | $8.66M | Buy |
110,878
+20,750
| +23% | +$1.63M | ﹤0.01% | 2150 |
|
|
2020
Q2 | $6.65M | Sell |
90,128
-210
| -0.2% | -$15.8K | ﹤0.01% | 2239 |
|
|
2020
Q1 | $6.63M | Sell |
90,338
-214,525
| -70% | -$16.9M | ﹤0.01% | 2048 |
|
|
2019
Q4 | $26.5M | Sell |
304,863
-132,467
| -30% | -$10.9M | ﹤0.01% | 1376 |
|
|
2019
Q3 | $35.1M | Buy |
437,330
+31,440
| +8% | +$2.52M | 0.01% | 1160 |
|
|
2019
Q2 | $32.5M | Sell |
405,890
-69,064
| -15% | -$5.29M | 0.01% | 1234 |
|
|
2019
Q1 | $37.7M | Buy |
474,954
+208,657
| +78% | +$15.6M | 0.01% | 1115 |
|
|
2018
Q4 | $19.4M | Buy |
266,297
+71,264
| +37% | +$5.03M | ﹤0.01% | 1514 |
|
|
2018
Q3 | $13.2M | Sell |
195,033
-315,553
| -62% | -$20.1M | ﹤0.01% | 1978 |
|
|
2018
Q2 | $29.6M | Buy |
510,586
+135,088
| +36% | +$7.62M | 0.01% | 1307 |
|
|
2018
Q1 | $19.5M | Buy |
375,498
+75,456
| +25% | +$4.08M | ﹤0.01% | 1529 |
|
|
2017
Q4 | $16.1M | Buy |
300,042
+151,750
| +102% | +$8.41M | ﹤0.01% | 1745 |
|
|
2017
Q3 | $9.1M | Buy |
148,292
+43,492
| +42% | +$2.64M | ﹤0.01% | 2058 |
|
|
2017
Q2 | $6.41M | Sell |
104,800
-4,871,104
| -98% | -$297M | ﹤0.01% | 2303 |
|
|
2017
Q1 | $302M | Sell |
4,975,904
-125,131
| -2% | -$7.59M | 0.07% | 285 |
|
|
2016
Q4 | $287M | Buy |
5,101,035
+1,059,377
| +26% | +$62M | 0.07% | 291 |
|
|
2016
Q3 | $241M | Buy |
4,041,658
+39,492
| +1% | +$2.31M | 0.06% | 326 |
|
|
2016
Q2 | $220M | Buy |
4,002,166
+3,488,646
| +679% | +$186M | 0.05% | 343 |
|
|
2016
Q1 | $25.9M | Sell |
513,520
-350,242
| -41% | -$17.2M | 0.01% | 1171 |
|
|
2015
Q4 | $43.5M | Buy |
863,762
+404,591
| +88% | +$20.4M | 0.01% | 881 |
|
|
2015
Q3 | $21.6M | Buy |
459,171
+318,529
| +226% | +$16.9M | 0.01% | 1213 |
|
|
2015
Q2 | $7.64M | Sell |
140,642
-97,607
| -41% | -$5.47M | ﹤0.01% | 2117 |
|
|
2015
Q1 | $13.1M | Sell |
238,249
-18,930
| -7% | -$1.07M | ﹤0.01% | 1719 |
|
|
2014
Q4 | $13.9M | Sell |
257,179
-69,797
| -21% | -$3.89M | ﹤0.01% | 1717 |
|
|
2014
Q3 | $18.5M | Buy |
+326,976
| New | +$18.4M | ﹤0.01% | 1495 |
|
|
2014
Q2 | – | Sell |
-14,882
| Closed | -$806K | – | 3585 |
|
|
2014
Q1 | $806K | Sell |
14,882
-59,107
| -80% | -$3.06M | ﹤0.01% | 2945 |
|
|
2013
Q4 | $3.53M | Sell |
73,989
-110,398
| -60% | -$5.05M | ﹤0.01% | 2389 |
|
|
2013
Q3 | $8.38M | Sell |
184,387
-75,980
| -29% | -$3.47M | ﹤0.01% | 1864 |
|
|
2013
Q2 | $11.5M | Buy |
+260,367
| New | +$11.6M | ﹤0.01% | 1591 |
|
Other funds holding MRK
VCM
VPM
JP Morgan Chase's MRK Position: Q1 2026 in Review
JP Morgan Chase increased its Merck (MRK) stake by 81% in Q1 2026, buying an estimated $2.74B and bringing the position to 52,972,983 shares worth $6.26B. The position accounts for 0.4% of the portfolio, ranked #43.
JP Morgan Chase first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- JP Morgan Chase held 52,972,983 shares of Merck worth $6.26B as of Q1 2026.
- JP Morgan Chase bought 23,773,005 Merck shares in Q1 2026, an estimated $2.74B.
- Merck made up 0.4% of JP Morgan Chase's portfolio in Q1 2026, its #43 holding.
- JP Morgan Chase first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.